In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent is better perceived by patients, the fragmented technology landscape sites have to navigate, the plain-language and health-literacy challenges baked into consent forms, and the timeline and budget pressures that keep eConsent from being standard practice. They also cover why pediatric and rare disease studies could be the fastest path to wider adoption, and how reconsent, an often-overlooked, recurring part of the process, is particularly well suited to going digital.
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire,...
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician...
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA &...
